HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rogier Versteeg Selected Research

Otx Transcription Factors

3/2013OTX2 sustains a bivalent-like state of OTX2-bound promoters in medulloblastoma by maintaining their H3K27me3 levels.
7/2012OTX2 directly activates cell cycle genes and inhibits differentiation in medulloblastoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rogier Versteeg Research Topics

Disease

63Neuroblastoma
01/2022 - 03/2002
52Neoplasms (Cancer)
01/2022 - 03/2002
10Medulloblastoma
07/2014 - 02/2006
5Residual Neoplasm
01/2019 - 11/2008
4Carcinogenesis
05/2016 - 12/2012
3Ganglioneuroma
05/2009 - 04/2008
2Primitive Neuroectodermal Tumors (PNET)
02/2016 - 04/2002
2Osteosarcoma (Osteogenic Sarcoma)
01/2016 - 12/2014
2Tics (Tic)
02/2014 - 03/2012
2Astrocytoma (Pilocytic Astrocytoma)
08/2013 - 12/2006
2Brain Neoplasms (Brain Tumor)
08/2013 - 07/2012
2Hypoxia (Hypoxemia)
01/2013 - 07/2010
1Colitis
01/2018
1B-Cell Lymphoma (Lymphoma, B Cell)
05/2016
1Retinoblastoma (Glioblastoma, Retinal)
11/2015
1Wilms Tumor (Wilm's Tumor)
02/2015
1Kidney Neoplasms (Kidney Cancer)
01/2015
1Disease Progression
01/2015
1Breast Neoplasms (Breast Cancer)
06/2014
1Genomic Instability
08/2013
1Chromosomal Instability (Chromosome Stability)
08/2013
1Ganglion Cysts (Ganglion)
07/2013

Drug/Important Bio-Agent (IBA)

19Messenger RNA (mRNA)IBA
01/2019 - 03/2002
17Proteins (Proteins, Gene)FDA Link
01/2018 - 03/2002
7Transcription Factors (Transcription Factor)IBA
11/2018 - 02/2008
7DNA (Deoxyribonucleic Acid)IBA
10/2018 - 05/2011
6Pharmaceutical PreparationsIBA
10/2020 - 08/2009
6MicroRNAs (MicroRNA)IBA
02/2015 - 12/2011
5Adrenergic Agents (Adrenergic Drugs)IBA
01/2022 - 05/2009
5Small Interfering RNA (siRNA)IBA
06/2015 - 04/2005
4Histones (Histone)IBA
01/2017 - 03/2009
4ChromatinIBA
03/2016 - 04/2008
4Phosphotransferases (Kinase)IBA
07/2015 - 04/2008
4Biological ProductsIBA
10/2012 - 01/2004
4LigandsIBA
03/2010 - 04/2002
3Lysine (L-Lysine)FDA Link
01/2017 - 03/2009
3RNA (Ribonucleic Acid)IBA
01/2015 - 12/2012
3beta CateninIBA
08/2008 - 04/2008
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2003 - 04/2002
2Anaplastic Lymphoma KinaseIBA
01/2022 - 09/2010
2Ornithine Decarboxylase (Decarboxylase, Ornithine)IBA
04/2021 - 05/2010
2PolyaminesIBA
04/2021 - 05/2010
2EnzymesIBA
04/2021 - 03/2009
2MethyltransferasesIBA
01/2017 - 10/2016
2GlypicansIBA
12/2016 - 10/2016
2glycerophosphodiester phosphodiesteraseIBA
12/2016 - 10/2016
2RoscovitineIBA
01/2016 - 08/2009
2Histone DemethylasesIBA
06/2015 - 03/2009
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2015 - 07/2010
2Biomarkers (Surrogate Marker)IBA
01/2015 - 04/2013
2Otx Transcription FactorsIBA
03/2013 - 07/2012
2Oxygen (Dioxygen)IBA
01/2013 - 07/2010
2N-Myc Proto-Oncogene ProteinIBA
11/2012 - 11/2012
2SurvivinIBA
03/2012 - 10/2011
2Tretinoin (Retinoic Acid)FDA LinkGeneric
07/2010 - 04/2009
2Nerve Growth Factor Receptors (Neurotrophin Receptors)IBA
05/2009 - 01/2004
2Cyclin D1IBA
04/2008 - 03/2003
2TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA
11/2003 - 04/2002
1Oncogene Proteins (Oncogene Protein)IBA
04/2021
1CytosineIBA
01/2021
1AdenineFDA LinkGeneric
01/2021
1dimethylaniline monooxygenase (N-oxide forming) (flavin-containing monooxygenase)IBA
01/2019
1Histone Deacetylase InhibitorsIBA
01/2019
1ElementsIBA
01/2018
1Smoothened ReceptorIBA
01/2018
1Dextrans (Dextran)FDA Link
01/2018
1sodium sulfate (sodium bisulfate)FDA LinkGeneric
01/2018
1Histone MethyltransferasesIBA
01/2017
1Polycomb Repressive Complex 2IBA
01/2017
1GSK-2816126IBA
01/2017
1Membrane Glycoproteins (Membrane Glycoprotein)IBA
10/2016
1venetoclaxIBA
05/2016
1Apoptosis Regulatory ProteinsIBA
05/2016
1hydrogen sulfite (bisulfite)IBA
03/2016
1lorlatinibIBA
01/2016
1Complementary DNA (cDNA)IBA
01/2016
14- (2,6- dichlorobenzoylamino)- 1H- pyrazole- 3- carboxylic acid piperidin-4-ylamideIBA
11/2015
1NucleophosminIBA
11/2015
1Cyclin-Dependent Kinases (cdk Proteins)IBA
11/2015
1Cyclin-Dependent Kinase 2IBA
11/2015
1AgarIBA
07/2015
1Complement System Proteins (Complement)IBA
05/2015
13-Iodobenzylguanidine (Iobenguane)IBA
02/2015
1lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA
01/2015
12-(morpholin-4-yl)benzo(h)chromen-4-oneIBA
01/2015
1DNA-Activated Protein KinaseIBA
01/2015
1Polo-Like Kinase 1IBA
12/2014
1NMS P937IBA
12/2014
1Estrogen ReceptorsIBA
06/2014
1Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA
02/2014
1Histone ChaperonesIBA
02/2014
1Serum-Free Culture MediaIBA
02/2014
1Telomerase (Telomerase Reverse Transcriptase)IBA
08/2013
1Mitogen-Activated Protein KinasesIBA
08/2013
1Small Nucleolar RibonucleoproteinsIBA
08/2013
1Phosphatidylinositols (Phosphatidylinositol)IBA
04/2013

Therapy/Procedure

19Therapeutics
01/2022 - 12/2007
4Drug Therapy (Chemotherapy)
02/2015 - 07/2014
2Combined Modality Therapy
10/2016 - 11/2015
1Aftercare (After-Treatment)
11/2015